Celularity
CELU • NASDAQ
Celularity is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert Joseph Hariri, with a market cap of $33.7M.
CEORobert Joseph Hariri
Market Cap$33.7M
Biotechnology
Healthcare
Employees225.0
Websitecelularity.com
Country
United States of America
Next Earnings
Upcoming earnings announcement for Celularity
Date
Thursday, May 7, 2026 (in 3 months)
Timing
Before Market Open (9:00 AM New York)
Fiscal Period
Q4 2025
Earnings History
Past 12 earnings reports for Celularity
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Q3 2025 | -$0.88 | — | $5.3M | — |  10-Q |
| May 8, 2025 | Q4 2024 | $0.59 | — | $18.1M | — | 10-K/A |
| Dec 6, 2024 | Q3 2024 | -$0.73 | — | $9.3M | — | 10-Q |
| Nov 7, 2024 | Q2 2024 | -$0.30 | — | $12.1M | — | 10-Q |
| Oct 16, 2024 | Q1 2024 | -$1.03 | — | $14.7M | — | 10-Q |
| Jul 30, 2024 | Q4 2023 | $0.88 | — | $12.1MEst: $4.7M | +157.2% | 10-K |
| Jan 3, 2024 | Q3 2023 | -$5.00 | — | $3.8M | — | 10-Q |
| Aug 14, 2023 | Q2 2023 | -$2.70 | — | $2.9M | — | — |
| May 22, 2023 | Q1 2023 | -$4.10Est: -$0.24 | -1608.3% | $3.9M | — | — |
| Mar 31, 2023 | Q4 2022 | -$1.60Est: -$0.26 | -515.4% | $4.1MEst: $5.6M | -26.8% | — |
| Nov 10, 2022 | Q3 2022 | $0.30Est: -$0.26 | +215.4% | $4.1MEst: $5.7M | -28.0% | — |
| Aug 9, 2022 | Q2 2022 | -$2.60Est: -$0.26 | -900.0% | $3.8M | — | — |